During Wednesday’s Morning trade, Shares of Intrexon Corp (NYSE:XON), gained 0.38% to $31.52.
Intrexon Corporation, declared that it has reached a research partnership agreement with Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover and develop ActoBiotics® therapies directed against selected targets to treat Type 2 diabetes (T2D), obesity and/or metabolic disorders related to energy dysregulation. This deal was facilitated by Johnson & Johnson Innovation. Diabetes is one of recently’s most pressing health problems, afflicting more than 387 million people worldwide at a cost surpassing $376 billion.
Samuel Broder, M.D., SVP and Head of Intrexon’s Health Sector stated, “I am very happy we are partnering with Janssen to address Type 2 diabetes and related conditions. Through the use of Intrexon’s proprietary ActoBiotics® platform, we believe this partnershipwill make a noteworthy contribution to this substantial global health issue. The breadth of opportunity to treat an array of diseases with our versatile ActoBiotics® technology continues to expand.”
T2D is a chronic syndrome resulting from dysregulation of blood sugar levels. Current treatments generally target only specific aspects of the disease, leaving other related complications insufficiently addressed. Intrexon’s ActoBiotics® platform represents an innovative oral delivery system for biological effectors ideally suited to tackle multiple aspects of T2D with the potential to improve efficacy in maintaining glycemic control in the long term.
Intrexon Corporation, a biotechnology company, operates in the synthetic biology field in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that comprise of key genetic components.
Shares of Ctrip.com International, Ltd. (ADR) (NASDAQ:CTRP), inclined 0.70% to $48.87, during its current trading session.
Nasdaq, declared the results of the annual re-ranking of the NASDAQ-100 Index (Nasdaq:NDX), which will become effective before market open on Monday, December 21, 2015.
The following seven companies will be added to the Index: Ctrip.com International, Ltd. (CTRP), Endo International plc (ENDP), Expedia, Inc. (EXPE), Maxim Integrated Products, Inc. (MXIM), Norwegian Cruise Line Holdings Ltd. (NCLH), T-Mobile US, Inc. (TMUS) and Ulta Salon, Cosmetics & Fragrance, Inc. (ULTA).
The NASDAQ-100 Index is composed of the 100 largest non-financial companies listed on The Nasdaq Stock Market® and dates to January 1985 when it was launched together with the NASDAQ Financial-100 Index®, which is comprised of the 100 largest financial stocks on Nasdaq®. These indexes act as benchmarks for financial products such as options, futures, and funds. The NASDAQ-100 is re-ranked each year in December, timed to coincide with the quadruple witch expiration Friday of the quarter.
Ctrip.com International, Ltd., together with its auxiliaries, provides travel services for hotel accommodations, transportation ticketing services, packaged tours, and corporate travel administration in the People’s Republic of China.
Finally, Pentair plc. Ordinary Share (NYSE:PNR), gained 2.15%, and is now trading at $50.32.
Pentair plc (PNR), a global company assisting its customers produce more food, energy and efficiencies from each drop of water, and the Minnesota Vikings declared that Pentair has been named a Founding Partner of U.S. Bank Stadium and the Official Sustainable Water Partner of the Vikings. In an effort to minimize bottled water use at U.S. Bank Stadium, Pentair-filtered drinking water will be available at water-filling and drinking stations throughout the stadium, in addition to in the suites and clubs.
“Around the globe, Pentair works to assist improve the quality, quantity and reliability of freshwater delivery, and we are excited to bring this expertise to U.S. Bank Stadium here in the Land of 10,000 Lakes,” said Randall J. Hogan, Pentair Chairman and CEO. “This partnership demonstrates our `top to tap` capabilities, as our technologies are utilized both in the treatment of the source water from the Mississippi, in addition to at the point of consumption with the planned water stations.”
The Mississippi River, located just blocks away from U.S. Bank Stadium, is an important water source for the stadium and the metropolitan area. Pentair`s technology is utilized in a water treatment facility serving Minneapolis that filters and cleans water from the Mississippi for more than 500,000 residents. At the stadium, a combination of Pentair`s proprietary advanced filtration technologies will further enhance the taste and quality of the incoming city water.
Pentair plc operates as a diversified industrial manufacturing company in the United States, Europe, and internationally. The company operates through Valves & Controls, Technical Solutions, Flow & Filtration Solutions, and Water Quality Systems segments.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.